TAMCONTIN

This brand name is authorized in Nigeria.

Active ingredients

The drug TAMCONTIN contains one active pharmaceutical ingredient (API):

1	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-101181	Tablet	Tamcontin 0.4 mg Tablet TAB 0.4 mg 3 x 10's,10 x 10's (in Alu strips)	Controlled Release Tablets NF-PP-426018 Tamcontin 0.4mg TABLET (Controlled Release Tablets of Tamsulosin Hydrochloride 0.4mg) Tamsulosin Hydrochloride 0.412 BP ,Kolliwax CSA 50 (Cetostearyl Alcohol) 10.00 BP Lactose 60.00 BP Diluent Povidone (Kollidon-30) 4.00 USP Binder Magnesium Stearate 1.00 BP Microcrystalline Cellulose 31.588 BP Hydroxyethylcellulose 10.00 BP Purified Talc 1.00 BP Glidant Purified Water 64.0 Drugs Imported Products 310,1010 POM 2 7/5/2024 PHILLIPS PHARMACEUTICALS (NIGERIA) LIMITED, 122-132 AFPRINT INDUSTRIAL ESTATE APAPA-OSHODI EXPRESSWAY IYANA-ISOLO LAGOS NIGERIA 8035493198 samson.omattah@phillipsnigeria.com MODI MUNDI PHARMA PVT LTD, MODIPURAM 250110 UP INDIA MEERUT MUZAFAAR NAGAR RD , India	30/01/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA02	Tamsulosin	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-101181